[Management of psoriasis vulgaris using an external sulfur mustard compound with special reference to its possible carcinogenic hazard (1st continuation and conclusion). Carcinogenesis of sulfur mustard compound in animal experiment and in man].
D000287:Administration, Topical; D000818:Animals; D002273:Carcinogens; D004781:Environmental Exposure; D005770:Gastrointestinal Neoplasms / Q000139:chemically induced; D006801:Humans; D008175:Lung Neoplasms / Q000139:chemically induced; D009150:Mustard Compounds / Q000009:adverse effects*; D009369:Neoplasms / Q000139:chemically induced*; D009784:Occupational Diseases / Q000139:chemically induced; D011565:Psoriasis / Q000188:drug therapy*; D012142:Respiratory Tract Neoplasms / Q000139:chemically induced; D012869:Skin Absorption; D012878:Skin Neoplasms / Q000139:chemically induced
D002273:Carcinogens; D009150:Mustard Compounds
Die Behandlung der Psoriasis vulgaris mit Schwefel-Lost extern unter besonderer Berücksichtigung ihres möglichen Carcinogenese-Risikos (1. Fortsetzung und Schluss). Zur Cancerogenität von Schwefel-Lost im Tier-Versuch und beim Menschen.